Literature DB >> 3709398

Effects of maternal glucose ingestion on human fetal breathing movements at weeks 24 and 28 of gestation.

J G Nijhuis, H W Jongsma, I J Crijns, I M de Valk, J W van der Velden.   

Abstract

The incidence of human fetal breathing movements was studied in normal pregnancies before and after administration of 50 g glucose or a placebo (water) at 24 and 28 weeks. Glucose or water was given to the same women on two separate days in a randomised order. No significant differences were present among the results on the placebo-day and the control period of the glucose-day at either gestational age. On the glucose-day, the incidence rose significantly from 3.6 to a maximum of 11.6% at 24 weeks, and from 6.7 to 30.2% at 28 weeks. At both ages the maximum was found 90-120 min after the intake of glucose. It is concluded that already at 24 weeks gestation the human fetus reacts with an increase of fetal breathing movements after the administration of glucose to the mother.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3709398     DOI: 10.1016/0378-3782(86)90006-x

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  4 in total

Review 1.  Maternal glucose administration for facilitating tests of fetal wellbeing.

Authors:  Kelvin H Tan; Antoinette Sabapathy
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

Review 2.  The role of CO(2) and central chemoreception in the control of breathing in the fetus and the neonate.

Authors:  Robert A Darnall
Journal:  Respir Physiol Neurobiol       Date:  2010-04-23       Impact factor: 1.931

Review 3.  The carotid body and arousal in the fetus and neonate.

Authors:  Robert A Darnall
Journal:  Respir Physiol Neurobiol       Date:  2012-06-08       Impact factor: 1.931

4.  The effect of glucose administration on perceived fetal movements in women with decreased fetal movement, a double-blinded placebo-controlled trial.

Authors:  N Michaan; Y Baruch; M Topilsky; S Amzalag; I Iaskov; A Many; S Maslovitz
Journal:  J Perinatol       Date:  2016-03-31       Impact factor: 2.521

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.